U.S. President Donald Trump fires defense secretary Mark Esper over public policy issues

U.S. President Donald Trump said on Monday that he had “terminated” Defense Secretary Mark Esper, appearing to use his final months in office after his election defeat to settle scores within his administration. Trump split with Esper over a range of issues and was particularly angered by Esper’s public opposition to Trump’s threats to use… Read More U.S. President Donald Trump fires defense secretary Mark Esper over public policy issues

U.S. FDA panel votes against Biogen’s Alzheimer drug

Biogen Inc’s shares slumped about 30% on Monday as the drugmaker’s chances of getting a regulatory approval for its experiment Alzheimer’s treatment suffered a blow after a panel of experts to the U.S. Food and Drug Administration voted against the medicine. Wall Street analysts largely believe the panel’s near-unanimous votes against the drug, aducanumab, make… Read More U.S. FDA panel votes against Biogen’s Alzheimer drug

Zoom to implement enhanced security in proposed settlement with U.S. FTC

Zoom Video Communications Inc must implement a new information security program as part of its proposed settlement with U.S. regulators over user privacy issues, the Federal Trade Commission said on Monday. The FTC, in a statement, said the company would face fines of up to $43,280 for each future violation under the agreement. The FTC… Read More Zoom to implement enhanced security in proposed settlement with U.S. FTC

Russia says its Sputnik V coronavirus vaccine over 90% effective

Russia’s Sputnik V vaccine against COVID-19 is more than 90% effective, a representative of the health ministry said on Monday, citing data collated from vaccinations of the public rather than from an ongoing trial. The comments followed a statement earlier on Monday by vaccine developers Pfizer Inc and BioNTech, who said their experimental COVID-19 vaccine… Read More Russia says its Sputnik V coronavirus vaccine over 90% effective

Novavax set to begin U.S. trial of coronavirus vaccine

Novavax Inc said on Monday it was on track to begin a delayed U.S.-based late-stage study of its experimental coronavirus vaccine later this month. The company also said the vaccine, NVX-CoV2373, had gained the U.S. Food and Drug Administration’s “fast-track” status and that expected data from the trial could support U.S. authorization and approval. Novavax,… Read More Novavax set to begin U.S. trial of coronavirus vaccine

Hundreds dead as conflict in Ethiopia’s Tigray region escalates

An escalating conflict in Ethiopia’s restive Tigray region has killed hundreds of people, sources on the government’s side said, even as the prime minister sought on Monday to reassure the world his nation was not sliding into civil war. The flare-up in the northern area bordering Eritrea and Sudan threatens to destabilise Africa’s second most… Read More Hundreds dead as conflict in Ethiopia’s Tigray region escalates

Pfizer, BioNTech say their coronavirus vaccine over 90% effective

Pfizer Inc’s experimental COVID-19 vaccine was more than 90% effective based on initial trial results, the company said on Monday, a major victory in the fight against a pandemic that has killed over a million people and battered the world’s economy. Experts welcomed the first successful interim data from a large-scale clinical test as a… Read More Pfizer, BioNTech say their coronavirus vaccine over 90% effective

Hungary to close schools and restaurants, impose curfew following rise in coronavirus cases

Hungary will close secondary schools, universities and restaurants and will impose an extended night-time curfew as of midnight on Tuesday to curb a fast rise in coronavirus infections, Prime Minister Viktor Orban announced on Monday on his Facebook page. Orban said sports events will be held behind closed doors, and all gatherings will be banned.… Read More Hungary to close schools and restaurants, impose curfew following rise in coronavirus cases